Table 4.
B | SE | P | HR | 95% CI | ||
---|---|---|---|---|---|---|
Age | −0.008 | 0.055 | 0.885 | 0.992 | 0.891 | 1.105 |
Female sex | 1.430 | 0.665 | 0.031 | 4.180 | 1.136 | 15.374 |
Hypertension | −0.420 | 0.926 | 0.650 | 0.657 | 0.107 | 4.034 |
Diabetes mellitus | −1.918 | 1.508 | 0.203 | 0.147 | 0.008 | 2.823 |
Current smoking | 1.181 | 1.371 | 0.389 | 3.257 | 0.222 | 47.806 |
Obesity | −2.083 | 2.493 | 0.997 | 0.008 | 0.000 | 1.121 |
Dyslipidemia | 1.317 | 1.204 | 0.274 | 3.733 | 0.353 | 39.496 |
Family history of CAD | 0.120 | 1.512 | 0.937 | 1.127 | 0.058 | 21.829 |
TG | 0.026 | 0.009 | 0.003 | 1.027 | 1.009 | 1.044 |
TC | −0.031 | 0.236 | 0.895 | 0.969 | 0.610 | 1.540 |
HDL | 1.513 | 1.830 | 0.408 | 4.541 | 0.126 | 16.977 |
LDL | −0.192 | 0.744 | 0.797 | 0.826 | 0.192 | 3.548 |
HbA1c | 0.303 | 0.145 | 0.036 | 1.354 | 1.019 | 1.798 |
Hcy | 0.036 | 0.015 | 0.013 | 1.037 | 1.008 | 1.067 |
PCSK9 | 0.000 | 0.002 | 0.967 | 1.000 | 0.996 | 1.004 |
Hs-CRP | −0.007 | 0.059 | 0.908 | 0.993 | 0.885 | 1.114 |
Prior Statin treatment | 1.098 | 1.330 | 0.409 | 2.997 | 0.221 | 40.629 |
SYNTAX | 0.014 | 0.046 | 0.763 | 1.014 | 0.926 | 1.111 |
TG, total triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HbA1c, glycosylated hemoglobin A; Hcy, homocysteic acid; PCSK9, proprotein convertase subtilisin/kexin type 9; Hs-CRP, high-sensitive-C-reactive-protein.